* Vericel Corp VCEL.OQ VCEL.O is expected to show a rise in
quarterly revenue when it reports results on August 4.
* The Cambridge, Massachusetts-based company is expected to
report a 83.2% increase in revenue to $36.667 million from
$20.01 million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Vericel Corp is for a
loss of 8 cents per share. For the same quarter last year, the
company reported a loss of 18 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Vericel Corp is
$66, about 19.8% above its last closing price of $52.94.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.04 -0.04 -0.07 Missed -66.2
Dec. 31 2020 0.20 0.20 0.25 Beat 23.5
Sep. 30 2020 -0.07 -0.06 0.08 Beat 223.9
Jun. 30 2020 -0.18 -0.21 -0.18 Beat 12.9
Mar. -0.08 -0.08 -0.10 Missed -22.4
31 2020
Dec. 31 2019 0.20 0.20 0.20 Met 1.7
Sep. 30 2019 -0.04 -0.02 0.07 Beat 519.9
Jun. 30 2019 -0.46 -0.46 -0.05 Beat 89.2
This summary was machine generated August 2 at 12:45 GMT. All
figures in US dollars unless otherwise stated